\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationParis, France
The network of Health National Contact Points (HNN3.0) is organising a next Brokerage Event dedicated to Horizon Europe Health calls for proposals 2024 for which the involvement of partners with expertise in Social Sciences and Humanities (SSH) is of importance. This event is organised in collaboration with Net4Society, the network of Cluster 2 National Contact Points. The 7 call topics targeted by the event are listed on the event website.
This event is of interest to potential applicants to Horizon Europe Health 2024 calls who are looking for SSH partners and for SSH researchers who want to contribute to health-related projects. The event will include pitch sessions and bilateral meetings for participants to share their ideas and interests in the calls.
More information and registration on the event website. Registration deadline is 30 April 2023. For any further information on the event, please contact the French Health NCP team at: pcn-sante@recherche.gouv.fr
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
